A Study of Sympathetic Skin Response in persons with Type-2 Diabetes Mellitus
Main Article Content
Abstract
Background: Impairment in Autonomic nervous system constitutes to one of the most serious and important complications in persons with Diabetes. Noninvasive Sympathetic Skin Response (SSR) test assesses the impairment of the sympathetic fibers of the peripheral nerves is widely used and valid markers of autonomic neuropathy. Considering the cost effectiveness of these tests, SSR testing would help us in understanding the prevalence of autonomic dysfunction in patients with Type 2 Diabetes Mellitus (T2DM). Method: 30 adults diagnosed with T2DM and 25 normal healthy adults who volunteered to participate were assessed for SSR in their foot and hand. SSR was assessed using Neurowerk EMG/NCV equipment capable of assessing SSR. Electrical current was used on the median nerve at the wrist to elicit SSR. Results: SSR was elicited in all participants. In persons with T2DM, mean SSR latency and SSR Amplitude for the hand were 1.587 ± 0.759 secs and 1499 ± 1411 microVolt respectively. The mean SSR Latency and SSR Amplitude for the foot were 2.478 ± 1.247 secs and 39.2 ± 901.07 micro Volts respectively. Characteristics of the SSR curves were discussed. Conclusion: In persons with T2DM, mean SSR latency of hand and foot were 1.587 ± 0.759 and 2.478 ± 1.247 seconds respectively. Mean SSR amplitude of hand and foot were 1499 ± 1411 and 939.2 ± 901.07 microVolts respectively. Mean values SSR Latency & Amplitude of persons with T2DM were significantly different from that of normal healthy adult.
Keywords: Sympathetic Skin Response, Automonic dysfunction, Diabetes mellitus.
Article Details
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.
What are my rights as an author?
It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as
Author. Journal's standard policies allow the following re-use rights:
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to obtain publishing rights without restrictions.
- You may do whatever you wish with the version of the article you submitted to the journal.
- Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.
- You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.
- You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.
References
Yu TY, Lee MK. Autonomic dysfunction, diabetes and metabolic syndrome. J Diabetes Investig. 2021 Dec;12(12):2108-2111. doi: 10.1111/jdi.13691. Epub 2021 Oct 27. PMID: 34622579; PMCID: PMC8668070.
Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes care. 2003 May 1;26(5):1553-79.
Lin X, Chen C, Liu Y, Peng Y, Chen Z, Huang H, Xu L. Peripheral nerve conduction and sympathetic skin response are reliable methods to detect diabetic cardiac autonomic neuropathy. Frontiers in Endocrinology.
Sep 21;12:709114.
Lin X, Chen C, Liu Y, Peng Y, Chen Z, Huang H, Xu L. Peripheral nerve conduction and sympathetic skin response are reliable methods to detect diabetic cardiac autonomic neuropathy. Frontiers in Endocrinology. 2021 Sep 21;12:709114.
Ewing DJ, Clark BE. Diabetic autonomic neuropathy a clinical viewpoint. In: Diabetic neuropathy (ed) Dyck PJ, Thomas PK, Ashbury AK, Philadelphia, WB Saunders 1987, 66-88.
Shahani BT, Halperin JJ, Boulu Ph, Cohen J. Sympathetic skin response-
-a method of assessing unmyelinated axon dysfunction in peripheral neuropathies. J neurol Neurosurg Psychiatry 1984; 47: 536-542
Elie B, Guiheneuc P. Sympathetic Skin Response: normal response in different experimental conditions . Electroenceph Clin Neurophysiol 1990; 76: 258 – 267
Braune HJ. Early detection of Diabetic Neuropathy: A Neurophysiological study in 100 patients. Electromyogr clin Neurophysiol 1997; 37: 399-407
Aramaki S, Kira y, Hirasawa Y. A study of normal values and habituation Phenomenon of Sympathetic skin response. Amer J Phys Med Rehabil 1997; 76: 2-7
Drory VE, Korczyn AD. Sympathetic Skin response: Age effect.
Neurology 1993; 43: 1818-1820
Xiaopu Lin, Chuna Chen, Yingshan Liu, et al. Peripheral Nerve Conduction And Sympathetic Skin Response Are Reliable Methods to Detect Diabetic Cardiac Autonomic Neuropathy. Front Endocrinol (Lausanne). 2021; 12: 709114
Lee, In Sung , Kim, Hee Sang , Ahn, Kyong Hoi. Sympathetic skin response in diabetes mellitus. Journal of the Korean Academy of Rehabilitation Medicine 1993;17(2):165-176.
Nazhel B, Yetkin I, Irkeç C, Koçer B. Sympathetic skin response in diabetic neuropathy. 2002, 42(3):181-185
Gutrecht JA. Sympathetic skin response. J Clin Neurophysiol1994; 11(5): 519-524
Kim CT, Chun SI. Sympathetic skin response recorded by 4 channel recording system. Yonsei Med J. 1994;35(2):149-54. doi: 10.3349/ymj.1994.35.2.149. PMID 8091791’